This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Intervertebral Disc Degeneration
Information about Intervertebral Disc Degeneration: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Intervertebral Disc Degeneration
Most recent studies have shown that Intervertebral Disc Degeneration shares some biological mechanisms with abnormal-degeneration, back-pain, degenerative-polyarthritis, disk-herniated, flexed-fetal-attitude, fracture, hernia, intervertebral-disk-displacement, low-back-pain, lumbar-disc-degenerative-disorder, osteophyte, pain, radiculopathy, scoliosis-unspecified, spinal-diseases, spinal-stenosis, spondylolisthesis, spondylosis, stenosis.
Among the many pathways, these few ones have gauged particular interests from scientists studying Intervertebral Disc Degeneration, and have been seen in publications frequently: Aging, Cell Death, Cell Growth, Cell Proliferation, Cellular Senescence, Innervation, Localization, Ossification, Pathogenesis, Programmed Cell Death, Proteolysis, Reflex, Regeneration, Reverse Transcription, Secretion, Senescence, Tissue Regeneration, Translation, Transport, Tropism
Quite a number of genes have been found to play important roles in Intervertebral Disc Degeneration, such as ACAN, BMP2, BMP7, CERS2, FTH1, IL6, IVD, KRT5, LBP, MMP3, RPL3, RPL4, RPL5, RPSA, SS18L1, TIMP1, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.